Header Logo

Connection

Debra Ritzwoller to Breast Neoplasms

This is a "connection" page, showing publications Debra Ritzwoller has written about Breast Neoplasms.
Connection Strength

2.278
  1. Regarding the Utility of Unstructured Data and Natural Language Processing for Identification of Breast Cancer Recurrence. JCO Clin Cancer Inform. 2021 09; 5:1024-1025.
    View in: PubMed
    Score: 0.440
  2. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627.
    View in: PubMed
    Score: 0.375
  3. Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128.
    View in: PubMed
    Score: 0.355
  4. Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281.
    View in: PubMed
    Score: 0.345
  5. Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194.
    View in: PubMed
    Score: 0.330
  6. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005 Mar; 7(3):191-7.
    View in: PubMed
    Score: 0.140
  7. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
    View in: PubMed
    Score: 0.068
  8. Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015 Jun; 9(2):201-7.
    View in: PubMed
    Score: 0.068
  9. Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
    View in: PubMed
    Score: 0.064
  10. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012 Nov 15; 118(22):5644-51.
    View in: PubMed
    Score: 0.057
  11. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Am J Manag Care. 2005 Oct; 11(10):601-8.
    View in: PubMed
    Score: 0.036

© 2024 Kaiser Permanente